Cytoskeletal Remodelling as an Achilles’ Heel for Therapy Resistance in Melanoma

Melanoma is an aggressive skin cancer with a poor prognosis when diagnosed late. MAPK-targeted therapies and immune checkpoint blockers benefit a subset of melanoma patients; however, acquired therapy resistance inevitably arises within a year. In addition, some patients display intrinsic (primary)...

Descripción completa

Detalles Bibliográficos
Autores principales: Barreno, Adrian, Orgaz, Jose L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834185/
https://www.ncbi.nlm.nih.gov/pubmed/35159327
http://dx.doi.org/10.3390/cells11030518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834185/
https://www.ncbi.nlm.nih.gov/pubmed/35159327
http://dx.doi.org/10.3390/cells11030518

Ejemplares similares